What Is Endometriosis?

Endometriosis is a chronic inflammatory disease characterized by the presence of tissue similar to the endometrium (inner lining of the uterus) outside the uterine cavity. These ectopic implants respond to the hormones of the menstrual cycle, causing chronic inflammation, pain, and adhesions.

It affects approximately 6-10% of women of reproductive age — about 190 million women globally. The most common implantation sites are the ovaries, pelvic peritoneum, uterosacral ligaments, and rectovaginal septum. In rare cases, it can affect distant organs such as the diaphragm and pleura.

Diagnostic delay is one of the biggest problems in endometriosis — on average, 7 to 10 years elapse between symptom onset and definitive diagnosis. This delay results from societal normalization of menstrual pain and the lack of noninvasive diagnostic biomarkers.

1

Chronic Disease

Endometriosis is a chronic estrogen-dependent disease that requires long-term management. There is no definitive cure, but it is controllable.

2

Diagnostic Delay

Diagnosis takes an average of 7-10 years, resulting in disease progression and unnecessary suffering.

3

Pain and Infertility

The two main impacts are chronic pelvic pain (in 70-80%) and infertility (in 30-50% of affected women).

Pathophysiology

The most accepted theory for the origin of endometriosis is retrograde menstruation (Sampson theory): during menstruation, fragments of endometrium reflux through the fallopian tubes into the peritoneal cavity, where they implant and grow. Although 90% of women have retrograde menstruation, only a minority develop endometriosis — indicating that immunologic and genetic factors determine susceptibility.

Endometriotic implants establish an inflammatory microenvironment in the peritoneum. Macrophages, dysfunctional NK cells, and lymphocytes release cytokines (IL-1, IL-6, IL-8, TNF-alpha), growth factors (VEGF), and prostaglandins that promote implant survival, neoangiogenesis, and neurogenesis — the formation of new sensory nerve fibers that amplify pain.

Pathophysiology of endometriosis: retrograde menstruation, peritoneal implantation, chronic inflammation, neurogenesis, and central sensitization of pain
Pathophysiology of endometriosis: retrograde menstruation, peritoneal implantation, chronic inflammation, neurogenesis, and central sensitization of pain

Central sensitization explains why pain in endometriosis does not correlate well with the anatomic extent of the disease. Small peritoneal implants can cause intense pain, while bulky ovarian endometriomas can be asymptomatic. Chronic noxious stimulation reprograms the central nervous system, creating generalized visceral and somatic hyperalgesia.

Symptoms

Endometriosis symptoms are varied and can mimic many other conditions. The classic triad is progressive dysmenorrhea, deep dyspareunia, and chronic pelvic pain. However, up to 20-25% of women with endometriosis are asymptomatic.

Clinical Manifestations

  • Progressive dysmenorrhea

    Menstrual cramping that worsens over the years, does not respond well to NSAIDs, and impacts daily activities.

  • Chronic pelvic pain

    Noncyclic pelvic pain present for more than 6 months, which can be constant or intermittent.

  • Deep dyspareunia

    Pain on deep penetration during intercourse, suggesting implants in the rectovaginal septum or uterosacral ligaments.

  • Infertility

    Present in 30-50% of cases. Results from adhesions, tubal dysfunction, endometrial alterations, and follicular inflammation.

  • Catamenial dyschezia

    Pain on defecation during menstruation, suggesting implants in the rectovaginal septum or bowel.

  • Cyclic urinary symptoms

    Dysuria, urgency, or hematuria that worsens during menstruation, indicating bladder involvement.

  • Chronic fatigue

    Persistent fatigue disproportionate to effort, present in up to 50% of patients and linked to systemic inflammation.

Diagnosis

The definitive diagnosis historically requires surgical visualization (laparoscopy) with histopathologic confirmation. However, current ESHRE guidelines recommend that diagnosis can be clinical, based on symptoms and imaging studies, without the need for surgical confirmation to start treatment.

Transvaginal ultrasonography with bowel preparation and pelvic magnetic resonance imaging are capable of detecting deep endometriosis and endometriomas with good accuracy. CA-125 may be elevated, but it has low sensitivity and specificity, and is not recommended as a stand-alone diagnostic test.

Endometriosis Classification

  1. Superficial peritoneal endometriosis: implants on the peritoneal surface
  2. Ovarian endometrioma: ovarian cysts containing endometriotic content ("chocolate cysts")
  3. Deep infiltrating endometriosis: implants that penetrate more than 5 mm below the peritoneal surface
  4. Revised ASRM classification: stages I (minimal), II (mild), III (moderate), IV (severe)
  5. Anatomic stage does not correlate with pain intensity
6-10%
prevalence in women of reproductive age
7-10 years
average diagnostic delay
30-50%
of women with infertility have endometriosis
70-80%
have significant pelvic pain

Differential Diagnosis

Adenomyosis

  • Globular and enlarged uterus on examination
  • Predominant menorrhagia
  • Dysmenorrhea in women aged 35 years or older
Warning signs
  • Iron-deficiency anemia from heavy bleeding
Diagnostic testsTransvaginal ultrasonographyPelvic magnetic resonance imaging

Complement to chronic pain management alongside hormonal treatment

IBS with Pelvic Pain

Read more
  • Pain that improves with defecation
  • Altered bowel habit
  • Absence of deep dyspareunia
Warning signs
  • Rectal bleeding
  • Weight loss
Diagnostic testsRome IV criteriaColonoscopy if alarm signs

Modulation of intestinal visceral hypersensitivity

Interstitial Cystitis

Read more
  • Intense urinary urgency and frequency
  • Suprapubic pain that relieves with voiding
  • Negative urine cultures
Warning signs
  • Macroscopic hematuria
Diagnostic testsCystoscopy with hydrodistensionUrine culture

Reduced bladder hypersensitivity and pelvic pain modulation

Chronic Salpingitis

  • History of pelvic inflammatory disease
  • Bilateral adnexal pain
  • Fever or discharge in the acute phase
Warning signs
  • Fever and adnexal mass — tubo-ovarian abscess
Diagnostic testsTransvaginal ultrasonographyGynecologic examinationSTD serologies

Adjuvant for chronic residual pain after treatment of the infectious focus

Pelvic Floor Myofascial Dysfunction / Levator Ani Syndrome

Read more
  • Perineal/rectal pain and pain in the deep pelvic region
  • Worsens with prolonged sitting posture
  • No clear relation with the menstrual cycle
Diagnostic testsPhysical examination with palpation of pelvic floor musclesSpecialized medical assessment of the pelvic floor

Myofascial release and trigger-point work on the pelvic floor musculature

Adenomyosis

Adenomyosis is the condition closest to endometriosis and frequently coexists with it. While endometriosis implants endometrial tissue outside the uterus, adenomyosis involves invasion of the myometrium. Clinical differentiation rests on more prominent menorrhagia in adenomyosis and a globular uterus on examination.

Pelvic magnetic resonance imaging is the imaging study of choice to differentiate the two conditions, though coexistence is common. Hormonal treatment (mainly dienogest and the levonorgestrel IUD) is effective for both. Medical acupuncture helps manage chronic pain unresponsive to hormones.

IBS with Pelvic Pain

Irritable bowel syndrome and endometriosis are frequently confused — studies show up to 50% of women with endometriosis are initially diagnosed with IBS. Catamenial dyschezia (pain on defecation during menstruation) is an important clinical marker of rectovaginal endometriosis that differs from the IBS bowel pattern.

The differential key is how symptoms relate to the menstrual cycle: in endometriosis, intestinal symptoms worsen during menstruation; in IBS, the pattern is more diffuse and tied to diet and stress. Visceral convergence between bowel and pelvis explains the frequent clinical overlap.

Endometriosis

  • Intestinal symptoms worsen during menstruation
  • Catamenial dyschezia (pain on defecation during menstruation) is an important clinical marker of rectovaginal endometriosis
  • Deep dyspareunia is part of the classic triad

Irritable bowel syndrome

  • The pattern is more diffuse and tied to diet and stress
  • Pain that improves with defecation
  • Absence of deep dyspareunia

Chronic Salpingitis

Chronic salpingitis, resulting from previous episodes of pelvic inflammatory disease, can cause chronic pelvic pain with a pattern similar to endometriosis. Clinical distinction rests on a history of acute PID episodes, more bilateral pain, and the absence of the typical cyclic pattern of endometriosis.

Screening for STDs (Chlamydia trachomatis, Neisseria gonorrhoeae) is fundamental in the differential diagnosis. Adequate antibiotic treatment of acute episodes prevents chronicity. Acupuncture can help with chronic residual pain after the infectious focus is controlled.

Treatment

Endometriosis treatment depends on the patient's goals — pain control, fertility preservation, or both. The approach combines hormonal treatment to suppress implant growth, surgical treatment when indicated, and multimodal pain management.

Hormonal Treatment (First Line)

Progestins (dienogest 2 mg/day, levonorgestrel IUD) and continuous combined contraceptives. They suppress ovulation and estrogenic stimulation of implants. Effective for pain in 60-80% of cases.

GnRH Analogues and Antagonists

GnRH analogues (leuprolide, goserelin) or oral GnRH antagonists (elagolix, relugolix) — suppress ovarian function. Pairing them with add-back therapy (estradiol + norethindrone or equivalent) from the outset prevents bone loss and allows longer use as indicated by the gynecologist.

Surgical Treatment

Laparoscopy for excision or ablation of implants, resection of endometriomas, lysis of adhesions. Indicated for refractory disease, infertility, or organ obstruction.

Multimodal Pain Management

Pelvic physical therapy, cognitive behavioral therapy, neuromodulators (amitriptyline, gabapentin), acupuncture. Essential to address central sensitization and chronic pain.

Do

  • Include multimodal pain management, essential to address central sensitization and chronic pain
  • Seek early reproductive counseling if you want a future pregnancy

Avoid

  • Count on pregnancy as a cure: it can temporarily relieve symptoms, but it does not cure the disease
  • Replace hormonal treatment with acupuncture: it complements the treatment, it does not replace it
The essentials so far
  1. The approach combines hormonal treatment, surgical treatment when indicated, and multimodal pain management.
  2. Hormonal treatment is the first line, effective for pain in 60-80% of cases.
  3. Surgery does not cure endometriosis: recurrence is common, reaching about 40-50% within 5 years, and rates vary across studies.
Continue: acupuncture as treatment

Acupuncture as Treatment

Acupuncture is being investigated as a complementary therapy for endometriosis-related pain. The Cochrane review on acupuncture for endometriosis (Zhu et al., 2011) identified very limited evidence (based on 1 RCT, Wayne 2008) suggesting possible benefit — the evidence remains insufficient for firm conclusions, and larger subsequent trials are needed.

Proposed mechanisms — still under investigation — include modulation of central sensitization by activation of descending inhibitory pain pathways, possible reduction of inflammatory cytokines (TNF-alpha, IL-6), release of endorphins, and modulation of the autonomic nervous system. Acupuncture has been investigated as potentially relevant for the noncyclic chronic pain component, in which central sensitization appears to play an important role.

Acupuncture does not act on endometriotic implants themselves but can contribute to pain control within a multimodal approach. It is especially valued by patients who want to reduce medication burden or complement hormonal treatment with nonpharmacologic interventions.

Prognosis

Endometriosis is a chronic disease without a definitive cure, but control is possible in most cases. Continuous hormonal treatment can keep the disease in clinical remission. Spontaneous resolution is rare while ovarian function is active.

As for fertility, women with mild to moderate endometriosis can conceive naturally, while severe cases may require in vitro fertilization. Early reproductive counseling is essential for patients who want a future pregnancy.

After menopause, most patients experience significant symptom improvement as estrogen levels fall. However, hormone replacement therapy can reactivate the disease in a minority of cases.

60-80%
pain control with hormonal treatment
40-50%
recurrence within 5 years after surgery
50-70%
spontaneous pregnancy in mild-moderate disease
Menopause
significant improvement in most cases

Myths and Facts

Myth vs. Fact

Myth

Pregnancy cures endometriosis

Fact

Pregnancy can temporarily relieve symptoms through hormonal suppression, but it does not cure the disease. Symptoms frequently return after delivery and breastfeeding.

Myth

Hysterectomy cures endometriosis

Fact

Hysterectomy without oophorectomy does not guarantee cure, since peritoneal implants can persist under ovarian stimulation. Even with oophorectomy, recurrence occurs in 5-10% of cases.

Myth

Endometriosis only affects older women

Fact

Endometriosis can begin in adolescence, soon after menarche. Diagnostic delay makes it look like a disease of older women, but symptoms frequently start in youth.

Myth

Severe pain means extensive disease

Fact

Pain intensity does not correlate with anatomic extent. Superficial implants can cause severe pain through local neurogenesis, while large endometriomas can be asymptomatic.

When to Seek Help

If you suspect endometriosis, seek evaluation with a gynecologist — preferably one experienced in endometriosis. Early diagnosis and adequate treatment can prevent disease progression and preserve fertility.

Frequently Asked Questions